Evidence map›Paper›PMID 26155430›Full record

ArticleOncoimmunology2015

CD14

A Marijne Heeren, Gemma G Kenter, Ekaterina S Jordanova, Tanja D de Gruijl

Abstract read
In one paragraph

Article in Oncoimmunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Observational
  9. Review
  10. Review
  11. Efficacy of PD-1 blockade in cervical cancer is related to a CD8Journal for immunotherapy of cancer · 2019
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

A Marijne HeerenDepartment of Medical Oncology; VU University Medical Center-Cancer Center Amsterdam ; De Boelelaan, Amsterdam, The Netherlands ; Center Gynecological Oncology Amsterdam (CGOA); Department of Obstetrics and Gynecology; VU University Medical Center ; De Boelelaan, Amsterdam, The Netherlands.
Gemma G KenterCenter Gynecological Oncology Amsterdam (CGOA); Department of Obstetrics and Gynecology; VU University Medical Center ; De Boelelaan, Amsterdam, The Netherlands ; Center Gynecological Oncology Amsterdam (CGOA); Department of Gynecology; Netherlands Cancer Institute - Antoni van Leeuwenhoek ; Amsterdam, The Netherlands ; Center Gynecological Oncology Amsterdam (CGOA); Department of Obstetrics and Gynecology; Academic Medical Center ; Amsterdam, The Netherlands.
Ekaterina S JordanovaCenter Gynecological Oncology Amsterdam (CGOA); Department of Obstetrics and Gynecology; VU University Medical Center ; De Boelelaan, Amsterdam, The Netherlands.
Tanja D de GruijlDepartment of Medical Oncology; VU University Medical Center-Cancer Center Amsterdam ; De Boelelaan, Amsterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A number of studies point to an aberrant differentiation and accumulation of CD14

Indexed as

cervical cancerCOX, cyclooxygenaseDC, dendritic celldendritic cellsIL, interleukinimmunotherapyLVSI, lymphovascular space invasionmacrophagesMDSC, myeloid-derived suppressor cellsPD-L1PD-L1, programmed death-ligand 1PGE2, prostaglandin-E2TDLN, tumor-draining lymph nodeTreg, regulatory T celltumor-draining lymph nodestumor microenvironment

Identifiers

PMID26155430
PMCPMC4485785

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.